Novel biomarker found in ovarian cancer patients can predict response to therapy

12:01 EDT 20 Sep 2018 | ecancermedicalscience

Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but never to a cure. About 15...

More From BioPortfolio on "Novel biomarker found in ovarian cancer patients can predict response to therapy"